The Courtyard Ottawa East Is Honoured as a Top Performing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Courtyard Ottawa East Is Honoured as a Top Performing Hotel on the World's Largest Travel Website

OTTAWA--(Marketwired - May 31, 2013) - The recently opened Courtyard Ottawa East may be the new kid on the block in terms of local hotels, but its team has proven it knows what it's doing. TripAdvisor recently awarded the hotel a prestigious Certificate of Excellence, an honour bestowed upon only the top-performing 10 percent of businesses worldwide in the hospitality industry.

"Courtyard Ottawa East is pleased to receive a Certificate of Excellence," said Franco Falcucci, General Manager at Courtyard Ottawa East. "We strive to offer our customers a genuine experience, and this accolade is evidence that our hard work is translating into positive reviews on TripAdvisor."

To earn a Certificate of Excellence, a business must maintain a rating of four or higher (out of five), as determined by reviews from TripAdvisor travellers. Businesses must also be listed on TripAdvisor's website for at least 12 months, and the number of reviews a property receives is taken into account as well. Of these, only the top 10 percent receive an award.

As one of the newest hotels in Ottawa, the Courtyard Ottawa East is already establishing a reputation for ensuring a productive and pleasurable stay. Its accommodations include 397 spacious rooms with flat-screen HD televisions, wet bars, mini-refrigerators and microwaves. Plus its on-property restaurant, The Bistro, serves up quick and healthy options for every meal, along with beer and wine in the evening.

Business travellers, meanwhile, appreciate the free parking and complimentary high-speed internet throughout the hotel, media pods in the lobby and the mobile desks in the guestrooms. This Ottawa Conference Centre hotel , however, is a powerhouse when it comes to meeting space: their attached conference centre boasts thirty seven meeting rooms occupying an impressive 43,000 square feet. Add to that the fact that the hotel is conveniently accessible to and from the airport, and you have a property that's downright irresistible. Just ask TripAdvisor.

About Courtyard Ottawa East Located less than fifteen kilometres from the airport and minutes away from downtown Ottawa, the Courtyard Ottawa East feels like a haven from city congestion while still remaining very much plugged in to the outside world. With free parking and complimentary high-speed internet throughout the hotel, media pods and a touch-screen GoBoard (with access to news, weather and airport information) in the lobby, the Courtyard Ottawa East makes business travel a pleasure. Its attachment to their 43,000 square foot conference centre that holds 37 individual meeting spaces and 2 ballrooms also makes it a productive and versatile option. At the end of the day, guests can work out in the 24-hour fitness centre, have a drink in The Bistro or retire to their rooms where every amenity from flat-screen HD television to mobile desks awaits. Guestrooms also include microwaves, mini-refrigerators and wet bars to create a home-away-from-home feeling. Many guestrooms feature dramatic views of the city skyline, which may easily entice visitors to explore Ottawa's rich cultural landscape. Parliament Hill, Gatineau Park, the National Arts Centre and the RCMP Foundation are all within reach of this new and exciting Ottawa property.

200 Coventry Road · Ottawa, Ontario K1K 4S3 Canada

CONTACT: Jennifer Marshall Courtyard Ottawa East 1-613-741-9862 http://www.marriott.com/hotels/travel/yowoe-c...tawa-east/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading